Moxifloxacin in pharma franchise in West Bengal

Moxifloxacin in PCD pharma franchise in Mumbai

Moxifloxacin in top pharma company in Coimbatore

Moxifloxacin in pcd pharma supplier in Puducherry

Moxifloxacin In phama franchise company in India
Moxifloxacin in phama distributor in Udupi

Home/Products /moxifloxacin-400mg-tablet

Moxolunic 400 Tablet

Composition : Moxifloxacin (400mg)

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*5

Price : ₹135/-

Moxolunic 400 Tablet contains Moxifloxacin (400mg), a potent broad-spectrum antibiotic from the fluoroquinolone class. It is designed to treat various bacterial infections effectively. Moxifloxacin works by inhibiting the DNA-gyrase enzyme in bacteria, which is essential for their reproduction, leading to bacterial cell death. This action makes Moxifloxacin an effective treatment for respiratory, skin, and other serious infections.

Moxolunic 400 Tablet is used primarily for the treatment of infections caused by susceptible strains of bacteria. These infections may involve the lungs, skin, sinuses, and urinary tract, as well as other conditions where bacterial infections are present. The tablet offers convenience as it can be taken orally and is well absorbed in the gastrointestinal tract.

The combination of effectiveness and minimal resistance development makes Moxifloxacin an excellent choice for treating moderate to severe infections in both outpatient and inpatient settings. It is especially useful for treating community-acquired pneumonia, chronic bronchitis, acute bacterial sinusitis, and skin and soft tissue infections.

Read More

About the Product

Moxolunic 400 Tablet contains Moxifloxacin (400mg), a potent broad-spectrum antibiotic from the fluoroquinolone class. It is designed to treat various bacterial infections effectively. Moxifloxacin works by inhibiting the DNA-gyrase enzyme in bacteria, which is essential for their reproduction, leading to bacterial cell death. This action makes Moxifloxacin an effective treatment for respiratory, skin, and other serious infections.

Moxolunic 400 Tablet is used primarily for the treatment of infections caused by susceptible strains of bacteria. These infections may involve the lungs, skin, sinuses, and urinary tract, as well as other conditions where bacterial infections are present. The tablet offers convenience as it can be taken orally and is well absorbed in the gastrointestinal tract.

The combination of effectiveness and minimal resistance development makes Moxifloxacin an excellent choice for treating moderate to severe infections in both outpatient and inpatient settings. It is especially useful for treating community-acquired pneumonia, chronic bronchitis, acute bacterial sinusitis, and skin and soft tissue infections.

Common side effects may include: Nausea and vomiting Diarrhea Headache Dizziness Rash Serious side effects (less common) include: Tendon rupture or inflammation QT prolongation (irregular heart rhythm) Liver enzyme abnormalities Severe allergic reactions If any severe side effects occur, discontinue use and seek immediate medical attention.

Community-acquired pneumonia (CAP) Acute bacterial sinusitis Chronic bronchitis exacerbations Skin and soft tissue infections Urinary tract infections (UTI) Intra-abdominal infections (in combination with other antibiotics)

Use only as prescribed by a healthcare provider. Should not be used in patients with a history of tendon disorders or known allergies to quinolone antibiotics. Not recommended for use during pregnancy or breastfeeding unless clearly necessary. Can cause dizziness; avoid operating heavy machinery if affected. Complete the full course of treatment even if symptoms improve to prevent bacterial resistance.

Store at room temperature (15°C to 25°C). Keep away from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation